Research library · Genomics
A negative carrier screen still has a defined scope
Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.
A carrier-screening report marked “negative” can bring relief. It can also leave an unanswered question: negative for what, exactly? Before treating the result as a statement about every inherited condition, find the section explaining which conditions and variants the test assessed.
That is not an invitation to distrust all testing. It is a way to keep a useful result within its actual scope. Decisions about pregnancy and family planning deserve an explanation of what was checked, what remains possible and whether anything in the family history changes the conversation.
Start with the purpose of the test
The NHS Genomics Education Programme's carrier definition describes the term as generally referring to someone who has a variant associated with a genetic condition without having the condition themselves. The details depend on the condition and inheritance pattern. Carrier screening is therefore not simply another name for a general health check.
If the report arrived as one tile inside a consumer genetics dashboard, save the underlying report rather than only the summary colour. Look for the test name, laboratory, date and stated limitations. If those details are missing, ask the provider where to find them before building a family-planning decision around the result.
The FDA's guidance on direct-to-consumer tests explains that companies may test different sets of variants. A negative result can leave relevant variants unassessed. This is a test-scope limitation, not a reason to calculate your own residual risk from a list found online.
Residual risk belongs in the explanation
Residual risk means the possibility that remains after a negative result. ACOG's carrier-screening guidance explicitly states that screening will not identify everyone at risk and that residual risk needs discussion. The accessible official summary supports that principle; full-text access was unavailable, and this article does not claim a full-text assessment or provide a numerical estimate.
Ask what the laboratory's result excludes and what it cannot exclude. If a numerical estimate is offered, ask what assumptions and evidence it uses. The useful outcome is an explanation you can understand, not the smallest number obtainable by combining unrelated online calculators.
Keep the distinction between a condition not being included and an included condition returning a negative result. Those can look similar on a simplified dashboard but answer different questions. A blank tile, an unavailable report and a negative result should not be silently treated as equivalents.
Bring family information without guessing
The CDC's pregnancy and family-history guidance encourages discussing family history with a healthcare professional and, when possible, doing so before pregnancy. Information about a known condition or a relative's specific genetic result may help that discussion.
Write down what you know and where it came from. “My aunt said there is an inherited blood condition” is a starting point, not a confirmed diagnosis. If a relative is comfortable sharing a clinical letter, ask the healthcare team how to provide it securely. Do not pressure relatives to disclose reports or upload their data to an interpretation site.
You can also say that information is unavailable. Adoption, estrangement, bereavement and limited access to records can leave gaps. A missing family history should be described honestly; it should not be filled with assumptions to make a form look complete.
Ask for a plan that fits the situation
Useful appointment questions include whether the existing test answers the question being asked, whether a genetics referral is appropriate, and whether another person's testing would change the assessment. Which question matters most depends on the circumstances. This article recommends no reproductive choice and no universal test panel.
Save the explanation with the original report. If further testing is discussed, ask who will arrange it and who will explain the result. A negative screen can be valuable information without becoming a guarantee about a future child's health. For general answer-based lifestyle education, explore DomDNA's free educational health quiz. It does not provide carrier screening, interpret DNA or estimate reproductive risk.
Original source and access ledger
- NHS carrier definition
sourceDate: Updated 2020-06-03
type: Professional education glossary
population: Carrier status across differing inheritance patterns
endpoint: Definition, not test sensitivity
supportedClaimAndLimit: Carrier generally describes a variant associated with a condition without that condition; specifics vary. No blanket claim that all carriers lack symptoms.
fundingAndConflicts: NHS education; no numerical inheritance rule extrapolated.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- FDA consumer genetic test scope
sourceDate: Date not established; accessed 2026-10-04
type: Regulator consumer education
population: Users of direct-to-consumer tests
endpoint: Variant coverage and interpretation limits
supportedClaimAndLimit: Different tests assess different variants; a negative result can leave unassessed variants. Not a universal residual-risk calculator.
fundingAndConflicts: US regulatory context; not claimed to describe every UK clinical testing pathway.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- ACOG residual-risk principle
sourceDate: 2017-03
type: Professional committee-opinion official indexed summary
population: People considering carrier screening
endpoint: Counselling on residual risk
supportedClaimAndLimit: Screening cannot identify everyone at risk; negative-result residual risk needs discussion. Only this accessible summary principle is used.
fundingAndConflicts: Professional society guidance; full text and individual disclosures unavailable to this check.
accessEvidence: Official search-indexed summary accessed; direct full text returned HTTP 402. No full-text access claimed.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- CDC pregnancy family history
sourceDate: Date not established; accessed 2026-10-04
type: Government public-health guidance
population: People planning pregnancy or pregnant
endpoint: Family-history discussion and possible genetic counselling
supportedClaimAndLimit: Discuss known family diagnoses with a professional, preferably before pregnancy when possible. No reproductive choice or universal panel prescribed.
fundingAndConflicts: CDC education; US context, no NHS eligibility claim.
accessEvidence: Official source text opened and read via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
Download exact original article Markdown · Download exact source and unsent social pack
Finished companion media
Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.